FDA deems Orchestra BioMed's sirolimus-eluting balloon a breakthrough device for coronary restenosis - FierceBiotech

FDA deems Orchestra BioMed's sirolimus-eluting balloon a breakthrough device for coronary restenosis  FierceBiotech

The drug-eluting balloon opens up the coronary arteries after they've reclogged without using a traditional drug coating.